Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial von Yau, Thomas, Park, Joong-Won, Finn, Richard S, Cheng, Ann-Lii, Mathurin, Philippe, Edeline, Julien, Kudo, Masatoshi, Harding, James J, Merle, Philippe, Rosmorduc, Olivier, Wyrwicz, Lucjan, Schott, Eckart, Choo, Su Pin, Kelley, Robin Kate, Sieghart, Wolfgang, Assenat, Eric, Zaucha, Renata, Furuse, Junji, Abou-Alfa, Ghassan K, El-Khoueiry, Anthony B, Melero, Ignacio, Begic, Damir, Chen, Gong, Neely, Jaclyn, Wisniewski, Tami, Tschaika, Marina, Sangro, Bruno

Volltext

Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies von Harding, James J, Nandakumar, Subhiksha, Armenia, Joshua, Khalil, Danny N, Albano, Melanie, Ly, Michele, Shia, Jinru, Hechtman, Jaclyn F, Kundra, Ritika, El Dika, Imane, Do, Richard K, Sun, Yichao, Kingham, T Peter, D'Angelica, Michael I, Berger, Michael F, Hyman, David M, Jarnagin, William, Klimstra, David S, Janjigian, Yelena Y, Solit, David B, Schultz, Nikolaus, Abou-Alfa, Ghassan K

Volltext

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention von Lowery, Maeve A, Ptashkin, Ryan, Jordan, Emmet, Berger, Michael F, Zehir, Ahmet, Capanu, Marinela, Kemeny, Nancy E, O'Reilly, Eileen M, El-Dika, Imane, Jarnagin, William R, Harding, James J, D'Angelica, Michael I, Cercek, Andrea, Hechtman, Jaclyn F, Solit, David B, Schultz, Nikolaus, Hyman, David M, Klimstra, David S, Saltz, Leonard B, Abou-Alfa, Ghassan K

Volltext

Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trials von Harding, James J

Volltext

Immunotherapy in hepatocellular carcinoma: Primed to make a difference? von Harding, James J., Dika, Imane, Abou‐Alfa, Ghassan K.

Volltext

Rational development of combination therapies for biliary tract cancers von Harding, James J., Khalil, Danny N., Fabris, Luca, Abou-Alfa, Ghassan K.

Volltext

CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody von Farwell, Michael D, Gamache, Raymond F, Babazada, Hasan, Hellmann, Matthew D, Harding, James J, Korn, Ron, Mascioni, Alessandro, Le, William, Wilson, Ian, Gordon, Michael S, Wu, Anna M, Ulaner, Gary A, Wolchok, Jedd D, Postow, Michael A, Pandit-Taskar, Neeta

Volltext

Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic Treatments von Cowzer, Darren, Harding, James J

Volltext

Novel leak localization in pressurized pipeline networks using acoustic emission and geometric connectivity von Ozevin, Didem, Harding, James

Volltext

Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody von Harding, James J, Moreno, Victor, Bang, Yung-Jue, Hong, Min Hee, Patnaik, Amita, Trigo, José, Szpurka, Anna M, Yamamoto, Noboru, Doi, Toshihiko, Fu, Siqing, Calderon, Boris, Velez de Mendizabal, Nieves, Calvo, Emiliano, Yu, Danni, Gandhi, Leena, Liu, Zhuqing Tina, Galvao, Violeta Regnier, Leow, Ching Ching, de Miguel, Maria J

Volltext

Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment von Callahan, Margaret K, Rampal, Raajit, Harding, James J, Klimek, Virginia M, Chung, Young Rock, Merghoub, Taha, Wolchok, Jedd D, Solit, David B, Rosen, Neal, Abdel-Wahab, Omar, Levine, Ross L, Chapman, Paul B

Volltext

Vemurafenib Sensitivity Skin Reaction after Ipilimumab von Harding, James J, Pulitzer, Melissa, Chapman, Paul B

Volltext

In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine von Dunphy, Mark P S, Harding, James J, Venneti, Sriram, Zhang, Hanwen, Burnazi, Eva M, Bromberg, Jacqueline, Omuro, Antonio M, Hsieh, James J, Mellinghoff, Ingo K, Staton, Kevin, Pressl, Christina, Beattie, Bradley J, Zanzonico, Pat B, Gerecitano, John F, Kelsen, David P, Weber, Wolfgang, Lyashchenko, Serge K, Kung, Hank F, Lewis, Jason S

Volltext

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience von Glassman, Danielle C, Palmaira, Randze L, Covington, Christina M, Desai, Avni M, Ku, Geoffrey Y, Li, Jia, Harding, James J, Varghese, Anna M, O'Reilly, Eileen M, Yu, Kenneth H

Volltext

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma von Goyal, Lipika, Shi, Lei, Liu, Leah Y, Fece de la Cruz, Ferran, Lennerz, Jochen K, Raghavan, Srivatsan, Leschiner, Ignaty, Elagina, Liudmila, Siravegna, Giulia, Ng, Raymond W S, Vu, Phuong, Patra, Krushna C, Saha, Supriya K, Uppot, Raul N, Arellano, Ron, Reyes, Stephanie, Sagara, Takeshi, Otsuki, Sachie, Nadres, Brandon, Shahzade, Heather A, Dey-Guha, Ipsita, Fetter, Isobel J, Baiev, Islam, Van Seventer, Emily E, Murphy, Janet E, Ferrone, Cristina R, Tanabe, Kenneth K, Deshpande, Vikram, Harding, James J, Yaeger, Rona, Kelley, Robin K, Bardelli, Alberto, Iafrate, A John, Hahn, William C, Benes, Cyril H, Ting, David T, Hirai, Hiroshi, Getz, Gad, Juric, Dejan, Zhu, Andrew X, Corcoran, Ryan B, Bardeesy, Nabeel

Volltext

A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors von Harding, James J, Telli, Melinda, Munster, Pamela, Voss, Martin H, Infante, Jeffrey R, DeMichele, Angela, Dunphy, Mark, Le, Mai H, Molineaux, Chris, Orford, Keith, Parlati, Frank, Whiting, Sam H, Bennett, Mark K, Tannir, Nizar M, Meric-Bernstam, Funda

Volltext

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype von Lowery, Maeve A, Jordan, Emmet J, Basturk, Olca, Ptashkin, Ryan N, Zehir, Ahmet, Berger, Michael F, Leach, Tanisha, Herbst, Brian, Askan, Gokce, Maynard, Hannah, Glassman, Danielle, Covington, Christina, Schultz, Nikolaus, Abou-Alfa, Ghassan K, Harding, James J, Klimstra, David S, Hechtman, Jaclyn F, Hyman, David M, Allen, Peter J, Jarnagin, William R, Balachandran, Vinod P, Varghese, Anna M, Schattner, Mark A, Yu, Kenneth H, Saltz, Leonard B, Solit, David B, Iacobuzio-Donahue, Christine A, Leach, Steven D, O'Reilly, Eileen M

Volltext

Type III Solar Radio Burst Source Region Splitting due to a Quasi-separatrix Layer von McCauley, Patrick I., Cairns, Iver H., Morgan, John, Gibson, Sarah E., Harding, James C., Lonsdale, Colin, Oberoi, Divya

Volltext

Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma von Chami, Perla, Diab, Youssef, Khalil, Danny N, Azhari, Hassan, Jarnagin, William R, Abou-Alfa, Ghassan K, Harding, James J, Hajj, Joseph, Ma, Jennifer, El Homsi, Maria, Reyngold, Marsha, Crane, Christopher, Hajj, Carla

Volltext

Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma? von Harding, James J., Khalil, Danny N., Abou-Alfa, Ghassan K.

Volltext